129 related articles for article (PubMed ID: 10890163)
1. Convergent synthesis of ribonuclease L-active 2',5'-oligoadenylate-peptide nucleic acids.
Wang Z; Chen L; Bayly SF; Torrence PF
Bioorg Med Chem Lett; 2000 Jun; 10(12):1357-60. PubMed ID: 10890163
[TBL] [Abstract][Full Text] [Related]
2. 2,5-oligoadenylate-peptide nucleic acids (2-5A-PNAs) activate RNase L.
Verheijen JC; van der Marel GA; van Boom JH; Bayly SF; Player MR; Torrence PF
Bioorg Med Chem; 1999 Mar; 7(3):449-55. PubMed ID: 10220031
[TBL] [Abstract][Full Text] [Related]
3. 5'-O-dephosphorylated 2',5'-oligoadenylate (2-5A) with 8-methyladenosine at the 2'-terminus activates human RNase L.
Nagaoka K; Kitamura Y; Ueno Y; Kitade Y
Bioorg Med Chem Lett; 2010 Feb; 20(3):1186-8. PubMed ID: 20022497
[TBL] [Abstract][Full Text] [Related]
4. Introduction of 8-methyladenosine into 2', 5'-oligoadenylate (2-5A) 2'-terminus induces dramatic shift in binding site of RNase L.
Nagaoka K; Kito S; Kitamura Y; Ueno Y; Kitade Y
Nucleic Acids Symp Ser (Oxf); 2009; (53):123-4. PubMed ID: 19749291
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of 2',5'-oligoadenylate analogs possessing a linker moiety in the place of the second adenosine and their ability to activate human RNase L.
Nakamura T; Ito Y; Mochizuki M; Ueno Y; Kitade Y
Nucleic Acids Symp Ser (Oxf); 2007; (51):449-50. PubMed ID: 18029780
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of 2-5As possessing base-modified adenosines and their activities to human recombinant RNase L.
Kitade Y; Tanida Y; Tuboi T; Yoshimura A; Nakanishi M; Yatome C
Nucleic Acids Symp Ser; 2000; (44):29-30. PubMed ID: 12903252
[TBL] [Abstract][Full Text] [Related]
7. Solid-phase synthesis of 5'-triphosphate 2'-5'-oligoadenylates analogs with 3'-O-biolabile groups and their evaluation as RNase L activators and antiviral drugs.
Thillier Y; Stevens SK; Moy C; Taylor J; Vasseur JJ; Beigelman L; Debart F
Bioorg Med Chem; 2013 Sep; 21(17):5461-9. PubMed ID: 23810677
[TBL] [Abstract][Full Text] [Related]
8. Biologically active 2-5A analogs containing 3'-O,4'-C-propylene adenosine as potent RNase L agonists.
Morita K; Obika S; Imanishi T; Kitade Y; Koizumi M
Nucleic Acids Symp Ser (Oxf); 2008; (52):637-8. PubMed ID: 18776541
[TBL] [Abstract][Full Text] [Related]
9. Incorporation of a 4-hydroxy-N-acetylprolinol nucleotide analogue improves the 3'-exonuclease stability of 2'-5'-oligoadenylate-antisense conjugates.
Verheijen JC; van Roon AM; Meeuwenoord NJ; Stuivenberg HR; Bayly SF; Chen L; van der Marel GA; Torrence PF; van Boom JH
Bioorg Med Chem Lett; 2000 Apr; 10(8):801-4. PubMed ID: 10782690
[TBL] [Abstract][Full Text] [Related]
10. Molecular basis for recognition of 2',5'-linked oligoadenylates by the N-terminal ankyrin repeat domain of human ribonuclease L.
Tanaka N; Nakanishi M; Kusakabe Y; Goto Y; Kitade Y; Nakamura KT
Nucleic Acids Symp Ser (Oxf); 2005; (49):323-4. PubMed ID: 17150764
[TBL] [Abstract][Full Text] [Related]
11. Structural basis for recognition of 2',5'-linked oligoadenylates by human ribonuclease L.
Tanaka N; Nakanishi M; Kusakabe Y; Goto Y; Kitade Y; Nakamura KT
EMBO J; 2004 Oct; 23(20):3929-38. PubMed ID: 15385955
[TBL] [Abstract][Full Text] [Related]
12. Correlation of selective modifications to a 2',5'-oligoadenylate-3',5'-deoxyribonucleotide antisense chimera with affinity for the target nucleic acid and with ability to activate RNase L.
Xiao W; Li G; Maitra RK; Maran A; Silverman RH; Torrence PF
J Med Chem; 1997 Apr; 40(8):1195-200. PubMed ID: 9111293
[TBL] [Abstract][Full Text] [Related]
13. 5'-Phosphonate modified oligoadenylates as potent activators of human RNase L.
Lášek T; Petrová M; Košiová I; Šimák O; Buděšínský M; Kozák J; Snášel J; Vavřina Z; Birkuš G; Rosenberg I; Páv O
Bioorg Med Chem; 2022 Feb; 56():116632. PubMed ID: 35078032
[TBL] [Abstract][Full Text] [Related]
14. Delivery of 2-5A cargo into living cells using the Tat cell penetrating peptide: 2-5A-tat.
Zhou L; Thakur CS; Molinaro RJ; Paranjape JM; Hoppes R; Jeang KT; Silverman RH; Torrence PF
Bioorg Med Chem; 2006 Dec; 14(23):7862-74. PubMed ID: 16908165
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and RNAse L binding and activation of a 2-5A-(5')-DNA-(3')-PNA chimera, a novel potential antisense molecule.
Verheijen JC; Chen L; Bayly SF; Torrence PF; van der Marel GA; van Boom JH
Nucleosides Nucleotides Nucleic Acids; 2000; 19(10-12):1821-30. PubMed ID: 11200276
[TBL] [Abstract][Full Text] [Related]
16. Accelerating RNA decay through intervention of RNase L: alternative synthesis of composite 2',5'-oligoadenylate-antisense.
Torrence PF; Wang Z
Methods Enzymol; 2001; 342():20-8. PubMed ID: 11586893
[No Abstract] [Full Text] [Related]
17. Biologically stable 2-5A analogues containing 3'-O,4'-C-bridged adenosine as potent RNase L agonists.
Morita K; Kaneko M; Obika S; Imanishi T; Kitade Y; Koizumi M
ChemMedChem; 2007 Dec; 2(12):1703-7. PubMed ID: 17910011
[No Abstract] [Full Text] [Related]
18. Comparative study on the biological properties of 2',5'-oligoadenylate derivatives with purified human RNase L expressed in E. coli.
Yoshimura A; Nakanishi M; Yatome C; Kitade Y
J Biochem; 2002 Oct; 132(4):643-8. PubMed ID: 12359081
[TBL] [Abstract][Full Text] [Related]
19. A viral RNA competitively inhibits the antiviral endoribonuclease domain of RNase L.
Townsend HL; Jha BK; Han JQ; Maluf NK; Silverman RH; Barton DJ
RNA; 2008 Jun; 14(6):1026-36. PubMed ID: 18426919
[TBL] [Abstract][Full Text] [Related]
20. Recognition of 2',5'-linked oligoadenylates by human ribonuclease L: molecular dynamics study.
Maláč K; Barvík I
J Mol Model; 2014 Apr; 20(4):2123. PubMed ID: 24633766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
